Qiming Venture Partners USA

VC · Cambridge (United States)

VC

Seed

Series A

Healthcare

Cloud/SaaS

Sign up free to access full profile and submit your pitch.

About

Qiming Venture Partners USA is a venture capital firm that partners with innovative entrepreneurs to build transformative healthcare companies. Launched in 2017 as the US-based arm of Qiming Venture Partners, the firm operates out of Cambridge, Seattle, and San Francisco.

Investment Criteria

Other investors that have backed the same portfolio companies as Qiming Venture Partners USA. Expand any entry to see the shared portfolio companies.

• Qiming Venture Partners

  12 shared

  Shared portfolio companies

  • Amphivena Therapeutics, Inc.
  • Candid Therapeutics, Inc.
  • Cardialen, Inc.
  • Kezar Life Sciences, Inc.
  • Kira Pharmaceuticals
  • Korro Bio, Inc.
  • Madaket, Inc.
  • Nuvaira, Inc.
  • PrivaPath Diagnostics Limited
  • Renasant Bio, Inc.
  • Stellular Bio, Inc.
  • WindMIL Therapeutics, Inc.
• Vivo Capital

  5 shared

  Shared portfolio companies

  • Elevation Oncology, Inc.
  • Kira Pharmaceuticals
  • Stellular Bio, Inc.
  • Tourmaline Bio, Inc.
  • Ventyx Biosciences, Inc.
• Foresite Capital

  3 shared

  Shared portfolio companies

  • Abdera Therapeutics Inc.
  • Candid Therapeutics, Inc.
  • Kira Pharmaceuticals
• Abingworth

  2 shared

  Shared portfolio companies

  • ENTACT BIO LIMITED
  • Jasper Therapeutics, Inc.
• Aju IB Investment

  2 shared

  Shared portfolio companies

  • Amphivena Therapeutics, Inc.
  • Kezar Life Sciences, Inc.
• Atlas Venture

  2 shared

  Shared portfolio companies

  • Korro Bio, Inc.
  • Renasant Bio, Inc.
• DCVC

  2 shared

  Shared portfolio companies

  • Auron Therapeutics, Inc.
  • Umoja BioPharma, Inc.
• F-Prime Capital

  2 shared

  Shared portfolio companies

  • Madaket, Inc.
  • Tenpoint Therapeutics Limited
• Illumina Ventures

  2 shared

  Shared portfolio companies

  • Fuze Health Inc
  • PrivaPath Diagnostics Limited
• MPM Capital

  2 shared

  Shared portfolio companies

  • Amphivena Therapeutics, Inc.
  • Umoja BioPharma, Inc.